Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis C

  Free Subscription


16.09.2019

1 Clin Res Hepatol Gastroenterol
1 Hepatology
2 J Hepatol
1 J Infect Dis
6 J Viral Hepat
1 J Virol
2 PLoS One
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Res Hepatol Gastroenterol

  1. AGUIAR BF, Campos GRF, Rodrigues JPV, Marques NN, et al
    Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil.
    Clin Res Hepatol Gastroenterol. 2019 Sep 12. pii: S2210-7401(19)30181.
    PubMed     Text format     Abstract available


    Hepatology

  2. VERNA EC, Tsapepas D, Emond JC, Brown RS Jr, et al
    Utilization of HCV-Viremic Organs for HCV Negative Recipients: Is Practice Speeding Past the Evidence?
    Hepatology. 2019 Sep 10. doi: 10.1002/hep.30933.
    PubMed     Text format     Abstract available


    J Hepatol

  3. LEVADA K, Guldiken N, Zhang X, Vella G, et al
    Hsp72 protects from liver injury via attenuation of hepatocellular death, oxidative stress and JNK-signaling.
    J Hepatol. 2018 Jan 10. pii: S0168-8278(18)30008.
    PubMed     Text format     Abstract available

  4. AMPUERO J, Jimeno C, Quiles R, Rosales JM, et al
    Impact of comorbidities on patients outcomes after interferon-free therapy-induced viral eradication in hepatitis.
    J Hepatol. 2017 Dec 27. pii: S0168-8278(17)32535.
    PubMed     Text format     Abstract available


    J Infect Dis

  5. EMMANUEL B, El-Kamary SS, Magder LS, Stafford KA, et al
    Metabolic Changes in Chronic Hepatitis C Patients who Carry IFNL4-DeltaG and Achieve Sustained Virologic Response with Direct-Acting Antiviral Therapy.
    J Infect Dis. 2019 Aug 26. pii: 5554606. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Viral Hepat

  6. LAURSEN TL, Siggaard CB, Kazankov K, Sandahl TD, et al
    Time-dependent improvement of liver inflammation, fibrosis, and metabolic liver function after successful direct-acting antiviral therapy of chronic hepatitis C.
    J Viral Hepat. 2019 Sep 10. doi: 10.1111/jvh.13204.
    PubMed     Text format     Abstract available

  7. IRELAND G, Simmons R, Hickman M, Harris R, et al
    Data linkage to monitor hepatitis C-associated end-stage liver disease and hepatocellular carcinoma inpatient stays in England.
    J Viral Hepat. 2019 Sep 10. doi: 10.1111/jvh.13203.
    PubMed     Text format     Abstract available

  8. MILLER LS, Millman AJ, Lom J, Osinubi A, et al
    Defining the Hepatitis C Cure Cascade in an Urban Health System Using the Electronic Health Record.
    J Viral Hepat. 2019 Sep 10. doi: 10.1111/jvh.13199.
    PubMed     Text format     Abstract available

  9. SAINZ T, Fernandez McPhee C, Dominguez-Rodriguez S, Hierro L, et al
    Longitudinal Evolution Of Vertically HIV/HCV Coinfected Vs HCV Monoinfected Children.
    J Viral Hepat. 2019 Sep 13. doi: 10.1111/jvh.13206.
    PubMed     Text format     Abstract available

  10. BUCHANAN R, Cooper K, Grellier L, Khakoo SI, et al
    The testing of people with any risk factor for Hepatitis C in community pharmacies is cost effective.
    J Viral Hepat. 2019 Sep 13. doi: 10.1111/jvh.13207.
    PubMed     Text format     Abstract available

  11. RAO H, Song G, Li G, Yang Y, et al
    Safety and efficacy of coblopasvir and sofosbuvir in patients with genotype 1, 2, 3, and 6 HCV infections without or with compensated cirrhosis.
    J Viral Hepat. 2019 Sep 13. doi: 10.1111/jvh.13208.
    PubMed     Text format     Abstract available


    J Virol

  12. TSAI CN, Pan TC, Chiang CH, Yu CC, et al
    Serine 229 balances the hepatitis C virus nonstructural protein NS5A between hypo- and hyper-phosphorylated states.
    J Virol. 2019 Sep 11. pii: JVI.01028-19. doi: 10.1128/JVI.01028.
    PubMed     Text format     Abstract available


    PLoS One

  13. CROWLEY D, Cullen W, Lambert JS, Van Hout MC, et al
    Competing priorities and second chances - A qualitative exploration of prisoners' journeys through the Hepatitis C continuum of care.
    PLoS One. 2019;14:e0222186.
    PubMed     Text format     Abstract available

  14. REZAEI N, Asadi-Lari M, Sheidaei A, Khademi S, et al
    Liver cirrhosis mortality at national and provincial levels in Iran between 1990 and 2015: A meta regression analysis.
    PLoS One. 2019;14:e0198449.
    PubMed     Text format     Abstract available


    Transplantation

  15. CANNON RM, Locke JE, Orandi BJ, Anderson DJ, et al
    Impact of donor hepatitis C virus on kidney transplant outcomes for hepatitis C positive recipients in the direct acting antiviral era: time to revise the kidney donor risk index?
    Transplantation. 2019 Sep 9. doi: 10.1097/TP.0000000000002949.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: